Table 2.
Factors related to the occurrence of AAD.
| SCF group (n = 221) | TZP group (n = 135) | P | |
|---|---|---|---|
| Dosage (mg/kg/day) | 54.0 (36.0–105.8) | 94.5 (63.0–182.2) | / |
| Therapy course (day) | 8 (6–11) | 14 (8–21) | 0.001* |
| Number of DDDs used | 1.4 (1.0–1.5) | 1.0 (0.9–1.0) | <0.001* |
| Empiric therapy | 167 (76.32%) | 105 (77.78%) | 0.890 |
| Targeted therapy | 52 (23.68%) | 30 (22.22%) | |
| Combined antibiotics | 111 (50.23%) | 80 (59.26%) | 0.461 |
| Nutrition support | 167 (76.32%) | 125 (92.59%) | 0.165 |
*P < 0.05.
SCF, cefoperazone/sulbactam; TZP, piperacillin/tazobactam; AAD, antibiotic-related diarrhea; DDD, defined daily dose.